188 related articles for article (PubMed ID: 35173802)
1. Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic review.
Rajan P; Iglay K; Rhodes T; Girman CJ; Bennett D; Kalantar-Zadeh K
Therap Adv Gastroenterol; 2022; 15():17562848221074183. PubMed ID: 35173802
[TBL] [Abstract][Full Text] [Related]
2. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors for chronic obstructive pulmonary disease.
Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.
Al-Aly Z; Maddukuri G; Xie Y
Am J Kidney Dis; 2020 Apr; 75(4):497-507. PubMed ID: 31606235
[TBL] [Abstract][Full Text] [Related]
5. Proton-pump inhibitors and chronic kidney disease: Hidden consequences of an inappropriate drug use?
Schiffl H; Al-Nemnem E; Lang SM
Saudi J Kidney Dis Transpl; 2020; 31(2):312-319. PubMed ID: 32394903
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis.
Boonpheng B; Thongprayoon C; Bathini T; Sharma K; Mao MA; Cheungpasitporn W
World J Transplant; 2019 Jun; 9(2):35-47. PubMed ID: 31363460
[TBL] [Abstract][Full Text] [Related]
7. Does the long-term administration of proton pump inhibitors increase the risk of adverse cardiovascular outcomes? A ChatGPT powered umbrella review.
Teperikidis E; Boulmpou A; Potoupni V; Kundu S; Singh B; Papadopoulos C
Acta Cardiol; 2023 Nov; 78(9):980-988. PubMed ID: 37431972
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies.
Wu CC; Liao MH; Kung WM; Wang YC
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983271
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitors: More Indigestion than Relief?
Malavade P; Hiremath S
Indian J Nephrol; 2017; 27(4):249-257. PubMed ID: 28761226
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review.
Edinoff AN; Wu NW; Parker K; Dudossat E; Linquest L; Flanagan CJ; Dharani A; Patel H; Willett O; Cornett EM; Kaye AM; Kaye AD
Adv Ther; 2023 Jun; 40(6):2693-2709. PubMed ID: 37140707
[TBL] [Abstract][Full Text] [Related]
11. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
[TBL] [Abstract][Full Text] [Related]
12. PPIs and kidney disease: from AIN to CKD.
Moledina DG; Perazella MA
J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
[TBL] [Abstract][Full Text] [Related]
13. [What is the REAL long-term risk of proton pump inhibitors?].
Ribiere S; Guillaumot MA; Barré A; Abou Ali E; Barret M; Chaussade S; Coriat R
Presse Med; 2019 May; 48(5):503-510. PubMed ID: 30926204
[TBL] [Abstract][Full Text] [Related]
14. [Emergent adverse effects of proton pump inhibitors].
Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
[TBL] [Abstract][Full Text] [Related]
15. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
[TBL] [Abstract][Full Text] [Related]
16. The relationship between proton pump inhibitors and renal disease.
Morschel CF; Mafra D; Eduardo JCC
J Bras Nefrol; 2018; 40(3):301-306. PubMed ID: 30010692
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease.
Kamal F; Khan MA; Molnar MZ; Howden CW
J Clin Gastroenterol; 2018 Jul; 52(6):468-476. PubMed ID: 29668562
[TBL] [Abstract][Full Text] [Related]
18. Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis.
Makunts T; Cohen IV; Awdishu L; Abagyan R
Sci Rep; 2019 Feb; 9(1):2282. PubMed ID: 30783195
[TBL] [Abstract][Full Text] [Related]
19. Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysis.
Wang J; Wu Y; Bi Q; Zheng X; Zhang J; Huang W
Hepatol Int; 2020 May; 14(3):385-398. PubMed ID: 31912308
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]